A pilot placebo-controlled, double-blind, and randomized study on the cognition-enhancing benefits of a proprietary chicken meat ingredient in healthy subjects by Zain M Azhar et al.
Azhar et al. Nutrition Journal 2013, 12:121
http://www.nutritionj.com/content/12/1/121RESEARCH Open AccessA pilot placebo-controlled, double-blind, and
randomized study on the cognition-enhancing
benefits of a proprietary chicken meat ingredient
in healthy subjects
Zain M Azhar1*, Jamil O Zubaidah1, Khin ON Norjan1,2, Candy Yi-Jing Zhuang2 and Fai Tsang2Abstract
Background: It has long been postulated that the relative abundance of specific nutrients can affect cognitive
processes and emotions. Newly described influences of dietary factors on neuronal function and synaptic plasticity
have revealed some of the vital mechanisms that could be responsible for the action of diet on brain health and
cognitive function. Here, through a double-blind, randomized, placebo-controlled trial, we asked if the newly
discovered chicken meat ingredient-168 (CMI-168) could be beneficial to the cognitive function in healthy adults.
Methods: Normal, healthy subjects were supplemented with either placebo or CMI-168 for 6 weeks. The subjects
were given a series of cognitive tests to examine their levels of cognitive functioning at the beginning and end of
supplementation, as well as two weeks after termination of supplementation. The combination of these tests,
namely Digit Span Backwards, Letter-Number Sequencing, and the Rey Auditory Verbal Learning Test (RAVLT), was
used to assess the subjects’ attention and working memory. For all comparisons, the probability level of p < 0.05
was taken as statistically significant using repeated measure 2-way ANOVA followed by Bonferroni post-hoc test.
Results: Overall, subjects supplemented with CMI-168 showed significantly (p < 0.01) better performance in all
cognitive tests after 6 weeks’ supplementation compared to control and such superior performance was
maintained even 2 weeks after termination of supplementation.
Conclusions: The present study reveals the cognition-enhancing properties of a recently developed chicken meat
ingredient, likely arising from the promotion of attention and prefrontal cortex functions.
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To prosper and flourish in a rapidly changing world, we
must make the most of all our resources – both mental
and physical. Added to highly competitive work lives are
the rising demands from evolving family structures and
increased social responsibilities [1]. Consequently, long
working hours and disturbed work-life balance are com-
mon and these predispose individuals to long-term risk of
lifestyle-related disorders [2,3]. Importantly, apart from
the long-term health issues, productivity at work could* Correspondence: azharmz@hotmail.com
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reproduction in any medium, provided the oralso be impaired as a result of work stress and fatigue. As
such, the use of cognitive enhancers is particularly appeal-
ing. The term "cognitive enhancement" usually character-
izes interventions in humans that aim to improve mental
functioning beyond what is necessary to sustain or restore
good health. In spite of recent evidence supporting their
efficacies in cognitive enhancement, the potential use of
drugs to enhance cognition, emotion and executive func-
tion has raised debate on their ethical and safety concerns
[1,4]. On the other hand, although food has classically
been perceived as means to provide energy and building
materials to the body, its ability to prevent and protect
against diseases is starting to be recognized. In particular,
over the past decade, research has provided excitingtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ance of cognitive function [5,6]. Dietary factors can affect
multiple brain processes by regulation of neurotransmitter
pathways, synaptic transmission, membrane integrity and
signal transduction pathways [7,8]. However, despite a
substantial body of pre-clinical evidence supporting the ef-
ficacies of foods and supplements in cognition enhance-
ment, their efficacies in humans are yet to be conclusive.
Essence of Chicken (EOC) is an aqueous extract of
chicken meat with a long history of consumption across
Asian populations. Anecdotal evidence has long associ-
ated EOC with improving cognitive performance, espe-
cially related to learning and memory, as well as
executive function. Published research over the last dec-
ade has lent significant support to its benefits in cogni-
tive performance, particularly in the area of working
memory, attention and episodic memory [9-11]. EOC,
that is abundant in proteins, amino acids and peptides,
is prepared through a unique process that involves aque-
ous extraction of chicken meat at a specific environment
(e.g. temperature). Besides, it also contains bioactive
peptides such as carnosine and anserine which are ef-
fective antioxidants and could have other physiological
benefits to human health. This prompted further re-
search to identify potential bioactives that could have
cognition-enhancing benefits and resulted in the devel-
opment of a hydrolyzed chicken extract, namely chicken
meat ingredient-168 (CMI-168), designed for cognition-
enhancing benefits. Here, we aimed to characterize the
cognition-enhancing effects of CMI-168 in a group of
healthy subjects. Subjects were supplemented with either
placebo or CMI-168 for 6 weeks. Cognitive performance
of the subjects was examined using a battery of cognitive
tasks selectively assessing their working memory and at-
tention immediately before and after the supplementation,
as well as two weeks after the course of supplementation.
This post-supplementation assessment was helpful to
determine whether the benefits (if any) could be a re-




A total of 46 healthy male and female subjects aged be-
tween 35 and 65 years were recruited either as walk-in
or referred from their general practitioners for counsel-
ing for life-style related issues. They were not suffering
from any medical condition and did not require any
medication. Their psychological well-being was assessed
using General Health Questionnaire, Beck Anxiety In-
ventory, Beck Depression Inventory, and Sheehan Dis-
ability Scale and confirmed that they did not suffer from
other psychiatric disorders or serious medical illnesses.
The study adhered to the strict standard Good ClinicalPractice (GCP) of Malaysia and also Guidelines of Dec-
laration of Helsinki in dealing with human subjects.
Compliance of subjects was monitored by requesting
them to bring the unfinished or empty bottles to ex-
change for new ones. Data from subjects non-compliant
to the supplementation instructions was not included
for statistical analyses. At the end of the study, a total of
26 subjects were excluded from the data analyses due to
either non-compliance of supplementation or with-
drawal from the study. The remaining fully compliant
subjects consisted of 10 male and 10 female subjects re-
spectively. Each supplementation group consisted of 5 male
and 5 female subjects. Subjects were also required to pro-
vide a dietary diary throughout the study to determine if
there were any substantial variations among the subjects, as
well as any changes in the dietary profiles throughout the
study. All the subjects were on mixed diets that included
protein intake from sources such as eggs and meats from
their normal diets.
CMI-168
Chicken meat ingredient-168 (CMI-168) was a hydro-
lyzed chicken extract prepared from chicken meat that
had been processed by a proprietary technology, involv-
ing bio-processing and aqueous extraction. It was pro-
duced through the advancement and optimization of the
process used for production of essence of chicken
(EOC).
Test sample
Tablets containing the chicken meat ingredient-168 (CMI-
168) (335 mg per tablet) were prepared. Subjects were
supplemented with 2 tablets per day (i.e. 670 mg per day).
Placebo
Tablets containing, instead of CMI-168, 335 mg of
microcrystalline cellulose were prepared. Subjects were
supplemented with 2 tablets per day as the CMI-168-
supplemented group.
Both test sample and placebo were supplied by
Cerebos Pacific Limited, Singapore.
Study design
A randomized, double-blind, placebo-controlled study
was conducted to evaluate the effect of CMI-168 on cog-
nitive performance. Subjects were randomly divided into
2 groups, namely the placebo group and CMI-168 group.
Subjects were supplemented orally with either the pla-
cebo or test sample daily for 6 weeks. The subjects and
the investigator who conducted the tests were blinded to
the information about the group allocation and samples
provided. Instead, an independent investigator, who has
no information about the cognitive assessment and psy-
chological well-being, maintained the record of all the
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supplementation that subjects self-administered the sup-
plements (either placebo or CMI-168), the subjects were
required to return the unfinished supplements or empty
bottle before they were issued with new bottles of sup-
plements. There were about 20 subjects who did not
fully comply with the supplementation regime and their
data were excluded from the final statistical analyses.
Measurements
The subjects were examined using a battery of psycho-
logical assessments as well as cognitive performance tasks
at the beginning of study (day 0) and day 42 (week 6).
They were also tested on day 56 (week 8) to continue
monitoring the effects of CMI-168 on cognitive perform-
ance after termination of supplementation. This post-
supplementation assessment of cognition was intended to
provide information on the sustainability of the cognition-
enhancing benefits of CMI-168. The psychological assess-
ments were Beck Anxiety Inventory, Beck Depression
Inventory, General Health Questionnaire, Sheehan Dis-
ability Scale; the cognitive performance tasks were Digit
Span, Letter Number Sequencing and Rey Auditory
Verbal Learning Test (RAVLT). These pre- and post-
supplementation psychological assessments were helpful
to ensure that the subjects are free from any psychological
or psychiatric disorders at beginning of the study and
there was no negative psychological effect on the subjects
as a result of the supplementation.
Beck Anxiety Inventory and Beck Depression Inventory
Beck Anxiety Inventory (BAI) is a 21 item self report
scale designed to measure the severity of anxious symp-
toms [12]. The score ranges from 0–63. The test-retest
reliability is 0.75 and concurrent validity is 0.65 with
Hamilton rating score. Beck Depression Inventory (BDI)
is another self report scale that measures the severity of
depression symptoms [13]. The score ranges from 0–63.
Any score above 30 would indicate severe depression.
The normal range is 0–9. The test-retest reliability is 0.8
and it has a high validity index.
General Health Questionnaire
General Health Questionnaire (GHQ) is a structured
questionnaire validated for use in Malaysia in 1996 [14]. It
has become a commonly used instrument in multicentre,
international trials designed to detect psychiatric disor-
ders, particularly, states of depression, anxiety and psychi-
atric morbidity.
Sheehan Disability Scale
The Sheehan Disability Scale (SDS) was developed to as-
sess functional impairment in three inter-related do-
mains; work/school, social and family life [15]. It is abrief self-report tool with a 10 point visual analogue
scale. Scores above 5 are associated with significant
functional impairment.
Digit Span Backwards
The Digit Span assessment typically consists of Digit
Span Forwards and Digit Span Backwards. The Digit
Span Forwards is generally simpler task and is a measure
of short-term memory storage capacity. In contrast, as
the Digit Span Backwards [16] requires the subject to re-
call and repeat auditory information in the reverse se-
quence, it not only requires the short-term memory
storage capacity, but also involves the manipulation of
information within the phonological buffer. As such it is
also a measure of working memory. As one of our key
objectives of the current study is to understand how
CMI-168 could be beneficial to the cognitive resource
optimization for effective information processing and
manipulation, Digit Span Backwards task was employed
in this study to more selectively examine the working
memory. The subjects were presented with a series of
digits and were asked to immediately repeat them ver-
bally in reverse order. The length of the longest list a
subject can remember is that subject’s digit span.
Letter-Number Sequencing
Letter-Number Sequencing (LNS) requires the subject to
attend to a series of letters and numbers that have been
read to him or her, hold them in memory, manipulate
them into a new order, and repeat the sequence. It was
indicated while much of the variance on the LNS task
was explained by performance on the more traditional
Digit Span, additional unique prediction of LNS per-
formance are provided by measures of processing speed
and visual spatial working memory [17].
Rey Auditory Verbal Learning Test
The Rey Auditory Verbal Learning Test (RAVLT) is an
efficient neuropsychological instrument for evaluating
verbal memory and learning. It provides scores for
assessing immediate memory, new verbal learning, sus-
ceptibility to interference, retention of information after
a period of time, and memory recognition [18,19].
Briefly, it consists of 3 lists. The first list consists of 15
words and participants are allowed 3 attempts to re-
member as many words as possible (termed ‘Immediate
Memory’, ‘Best Learning’ and ‘Total Learning’ respect-
ively). Participants are then presented with a distractor
list (List B) followed by a free-recall test from List B
(termed ‘Proactive interference’). Immediately after, par-
ticipants are asked to recall List A (termed ‘Retroactive
interference’). After a 20 min interval, participants are
asked again to recall the words from List A (termed
‘Delayed Recall’). Finally, the last task presents a 3rd list
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need to identify the words that are part of List A
(termed ‘Recall’).
Statistics
Requirement of the sample size to provide statistical sig-
nificance was computed using Epi Info™ 7 software with
the anticipated effect size was 0.8, power of 0.8 and con-
fidence level of 95%. Statistical Package for Graphpad
Prism was used to analyze the data collected in this
study. All values are expressed as Score for each test. All
values were expressed as mean ± standard error of
mean (SEM). For all comparisons, the probability level
of p < 0.05 is considered to be statistically significant




Two groups of subjects consisting of a total of 46 subjects
were recruited for this study. The final number of subjects
whom the data was examined for statistical differencesFigure 1 Effects of a proprietary chicken meat ingredient-168 (CMI-168
DS-B; and (B) Letter-Number Sequencing, LNS. Each data point is represen
placebo group at the same time point.was 20. The reason for exclusion from statistical analyses
were either withdrawal from the study or non-compliant
to the supplementation regime. The sample size was veri-
fied using Epi Info™ 7 software to ensure the sample size is
sufficient for detecting differences between placebo and
CMI-168 supplementations. Among the 20 subjects, their
ages ranged from 35 to 65 years old (Mean age: 47.5 years
old). Each group consisted of 5 male and 5 females. None
of the participants reported any adverse effects during and
after the course of supplementation. For concealed alloca-
tion purpose, the investigator ruling participants eligible
for the trial did not know their group allocation when de-
termining eligibility.
Psychological profiles
There were no significant differences between the two
groups in the Beck Anxiety Inventory and Beck Depres-
sion Inventory (data not shown). These psychological as-
sessments confirmed that the subjects were normal and
free of any psychiatric disorders. From the clinical as-
sessment by the qualified psychiatrist in charge of this
clinical study, the subjects were only mildly stressed due) on working memory as examined by (A) Digit Span Backwards,
ted as mean ± S.E.M. (n = 10). ** p < 0.01, *** p < 0.001, compared with
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the study, there was also no significant difference be-
tween the 2 groups in General Health Questionnaire
and Sheehan Disability Scale, which also confirmed
that their psychological status was unchanged during
the study.Figure 2 Effects of a proprietary chicken meat ingredient-168 (CMI-16
verbal learning scores were reflected by (A) Immediate Learning, IL; (B) Bes
represented as mean ± S.E.M. (n = 10). *** p < 0.001, compared with placebCognitive assessments
(1) Attention & working memory
The Digit Span consists of two parts, Digits Forward and
Digits Backwards. It is also known as auditory vocal se-
quencing memory that requires the subjects to recall and
repeat auditory information in the proper sequences. The8) on verbal memory and learning as examined by RAVLT. New
t Learning, BL; and (C) Total Learning, TL. Each data point is
o group at the same time point.
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as a clinical note and throughout the study there was no
significant change (p > 0.05; data not shown) in all sub-
jects in their basic short-term memory storage capacity.
Both Digit Span Backwards and Letter-Number Sequen-
cing are useful in examining the subjects’ attention and
working memory. As shown in Figure 1, after a supple-
mentation of 6 weeks, subjects taking CMI-168 showed a
higher score compared to those taking placebo in both the
Digit Span Backwards and Letter Number Sequencing
tasks (p < 0.001). The better performance in CMI-168
group was maintained even 2 weeks (week 8) after termin-
ation of supplementation (p < 0.01).
(2) Verbal memory and learning
The Rey Auditory Verbal Learning Test (RAVLT) was used
to assess verbal memory and learning. Particularly, it is use-
ful for assessments of immediate memory related to new
verbal learning and the capability to retain information forFigure 3 Effects of a proprietary chicken meat ingredient-168 (CMI-16
Susceptibility to interference was determined by (A) Proactive Interference
detailed description of the assessments. Each data point is represented as m
the same time point.effective recall. The scores of verbal learning and memory
on the RAVLT also correlate strongly with executive func-
tion. Figure 2 shows that subjects taking CMI-168 scored
significantly higher (p < 0.001) compared to placebo group
in the RAVLT subtests of Immediate Memory, Best Learn-
ing and Total Learning. In the assessment of the suscepti-
bility to interference, subjects supplemented with CMI also
demonstrated more robust (p < 0.001) memory despite
interference (proactive and retroactive) compared to con-
trol (Figure 3). Further, the efficiency of information reten-
tion (as assessed by Delayed Recall) was shown to be
higher (p < 0.001) in subjects supplemented with CMI-168
compared with control (Figure 4A). Consistently, the
memory recognition, which is also a function of mem-
ory retention, the CMI-168-supplemented group was
also significantly (p < 0.001) superior relative to the
control group (Figure 4B).
Taken together, subjects supplemented with CMI-168
for 6 weeks showed better overall performance scores in8) on verbal memory and learning as examined by RAVLT.
, PI; and (B) Retroactive Interference, RI. Please refer to Methods for
ean ± S.E.M. (n = 10). *** p < 0.001, compared with placebo group at
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maintained even 2 weeks after termination of supple-
mentation. In the current study, the differences in cogni-
tive functions between male and female were not
determined as this was intended as a pilot study on the
cognition enhancing effects of CMI-168 and the sample
size was not large enough to provide a conclusive com-
parison between genders.
Discussion
In this study we explored the cognition-enhancing effect
of a proprietary chicken meat ingredient, CMI-168. Pre-
vious studies on EOC have demonstrated its benefits in
the maintenance of executive function under stress
[9-11], particularly in attention and working memory.
From an initial study intending to explore the mechan-
ism(s) through which EOC might work in the brain to
regulate cognitive function, we found that EOC seemed
to have modulatory effects in the serotonergic system inFigure 4 Effects of a proprietary chicken meat ingredient (CMI) on ve
retention and recognition were determined by (A) Delayed Recall, DR; and
(n = 10). *** p < 0.001, compared with placebo group at the same time pointthe brain [20]. This prompted us to further explore into
the bioactive ingredients that are responsible for the ob-
served benefits in cognitive function. Consequently, in
an attempt to engineer a more efficacious ingredient
through optimization of the proprietary process that
produces EOC, a chicken meat ingredient, CMI-168,
was developed. Interestingly, preliminary in vivo assess-
ment of CMI-168 indicated that it could promote more
selectively the learning and memory functions of the
mice [data not shown]. Naturally, one of the key ques-
tions would be to ask if this selective efficacy of en-
hanced learning and memory could be reproduced in
humans. This data, together with further in-depth mech-
anistic studies in vitro and in vivo, will then provide a
more encompassing understanding of the cognition-
enhancing properties of CMI-168.
As shown in Figure 1, subjects supplemented with CMI-
168 for 6 weeks showed significantly (p < 0.001) better
scores in both Digit Span Backwards and Letter-Numberrbal memory and learning as examined by RAVLT. Memory
(B) Recall, R respectively. Each data point is represented as mean ± S.E.M.
.
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gests a better ability in sequencing as well as a higher level
of attention and concentration. Besides, as both tests re-
quire manipulation of information within the phonological
buffer, they are measures of working memory as well. This
finding is in line with previous reports by Azhar and col-
leagues [8,9] and indicates that the cognition-enhancing
effect of CMI-168 correlates well with that of EOC. We
further examined, using RAVLT, the subjects’ verbal learn-
ing and memory capabilities. In the immediate recall tests,
subjects supplemented with CMI-168 showed significantly
better performance (Figure 2). This could result from an
enhanced ability to concentrate. This possibility is further
supported by the results of the subsequent sub-test on
the memory despite interference where the CMI-168-
supplemented group again performed significantly bet-
ter than the placebo group (Figure 3). Furthermore,
previous studies using RAVLT also suggest that inter-
ferences (i.e. proactive and retroactive interferences)
could have impact on both the normal functioning of
working memory and memory processes such as con-
solidation and storage [21-26]. Therefore, this suggests
efficacy for CMI-168 in the maintenance of the proper
functioning of working memory as well as important
memory functions such as memory consolidation. Im-
portantly, these processes are pivotal contributory fac-
tors to effective learning. Further supporting the
notion that CMI-168 would be particularly beneficial
to learning, in the last part of RAVLT that assess the
efficiency of information retention through the delayed
recall and memory recognition tasks (Figure 4), CMI-
supplemented group showed a consistently superior
performance compared to placebo group. To help rule
out the possibility of a temporary equilibrating adjust-
ment of function due to supplementation of CMI-168,
rather than a sustainable improvement of cognitive
function, we conducted another cognitive assessment
two weeks after termination of supplementation. Inter-
estingly, in the post-supplementation cognitive assess-
ment, the CMI-168-supplemented group maintained
higher scores of performance in all tests in comparison
with the placebo group. Understanding that the central
activities of CMI-168 are associated with enhancement
of effective neuronal communications based on the
in vitro and in vivo findings (data not shown), it is pos-
sible that supplementation of CMI-168 might help
optimize the cognitive resources for effective PFC process-
ing and attentional network. This optimization of PFC
function would provide an advantage in the learning
process, particularly related to information acquisition,
processing and manipulation that are essential for
conceptualization and application of newly registered in-
formation. Additionally, the ability to maintain effective
memory functions such as memory consolidation wouldbe an important determinant of successful storage of
newly learned information and subsequent retrieval for
application in future. Thus it is plausible to hypothesize
that CMI-168 helps to maintain an effective network of
cognitive resources, particularly beneficial in the mainten-
ance of attention, working memory, as well as memory
functions such as memory storage and consolidation. This
hypothesis warrants further investigation in the applica-
tion of CMI-168 on the strengthening of the neural net-
works and functional connectivity related to PFC and
hippocampal functions. Although the present study was
not intended to investigate any differential responsiveness
to CMI-168 in the subjects, it does not rule out the possi-
bility that CMI-168 might have variation in the magnitude
of impact across individuals.
Conclusion
The present study reveals initial evidence supporting the
cognition-enhancing efficacy of a proprietary chicken
meat ingredient, CMI-168, in humans. This benefit
might be associated with its ability to maintain effective
cognitive resources in attention- and PFC-related execu-
tive functions, as well as memory processes that facilitate
consolidation and storage of newly learned information.
This initial evidence warrants further investigation into
the selectivity of the effects of CMI-168 in specific cog-
nitive processes in the prefrontal cortex, as well as
hippocampus in the learning process.
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